Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Sichuan Kelun Pharmaceutical Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 30 Dec 2022 | Sichuan Kelun Botai Biomedical Raises USD200 Million in Series B Financing | Venture Financing |
China Cinda Asset Management Co Ltd
SDIC Innovation Investment Management Co Ltd
IDG Capital
Sherpa Investments
Chengdu Guanghua Wutong Equity Investment Fund Management Co Ltd
Merck, Sharp & Dohme (China)
|
Sichuan Kelun Botai Biomedical Co Ltd
|
| 08 Jun 2022 | Yili Chuanning Biotechnology Completes Initial Public Offering of Shares for USD167 Million | Equity Offering | - |
Yili Chuanning Biotechnology Co Ltd
|
| 17 May 2022 | Merck Enters into Licensing Agreement with Sichuan Kelun Pharma | Licensing Agreement |
Merck & Co Inc
|
Sichuan Kelun Pharmaceutical Co Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer